Nyt fra tidsskrifterne
Søgeord (pseudomonas) valgt.
234 emner vises.
1
Gram-negative bloodstream infections in six German university hospitals, 2016–2020: clinical and microbiological features
Infection
Tilføjet 4.12.2024
2
In vitro activity of ceftazidime-avibactam/aztreonam combination against MBL-producing Pseudomonas aeruginosa strains
Infection
Tilføjet 4.12.2024
3
Microbiome analysis reveals the inducing effect of Pseudomonas on prostatic hyperplasia via activating NF-κB signalling
Virulence
Tilføjet 2.12.2024
4
Prevalence of bacterial ear infections and multidrug resistance patterns among ear infection suspected patients in Ethiopia: a systematic review and meta-analysis
BMC Infectious Diseases
Tilføjet 30.11.2024
5
Pseudomonas fluorescens
Trends in Microbiology
Tilføjet 29.11.2024
6
Research Letter - Canine Multidrug-Resistant Pseudomonas aeruginosa Cases Linked to Human Artificial Tears-Related Outbreak
Emerging Infectious Diseases
Tilføjet 26.11.2024
7
Evaluation of risk factors for 14-day and 30-day mortality among treatment regimens against Pseudomonas aeruginosa resistant to carbapenem but susceptible to traditional antipseudomonal non-carbapenem β-lactam agents
PLoS One Infectious Diseases
Tilføjet 20.11.2024
8
Bioenergetic suppression by redox-active metabolites promotes antibiotic tolerance in Pseudomonas aeruginosa
Proceedings of the National Academy of Sciences
Tilføjet 13.11.2024
9
Prevalence of blaOXA-48 and other carbapenemase encoding genes among carbapenem-resistant Pseudomonas aeruginosa clinical isolates in Egypt
BMC Infectious Diseases
Tilføjet 12.11.2024
10
Bacterial profile and antimicrobial susceptibility patterns of isolates from inanimate objects used by healthcare professionals at Debre Markos Comprehensive Specialized Hospital, Northwest Ethiopia
PLoS One Infectious Diseases
Tilføjet 12.11.2024
11
In vivo divergent evolution of cross-resistance to new β-lactam/β-lactamase inhibitor combinations in Pseudomonas aeruginosa following ceftazidime/avibactam treatment
Infection
Tilføjet 10.11.2024
12
Impact of Pseudomonas aeruginosa carriage on ICU-acquired pneumonia: a European multicentre prospective cohort study
Clinical Microbiology and Infection
Tilføjet 10.11.2024
13
Versatile properties of Opuntia ficus-indica (L.) Mill. flowers: In vitro exploration of antioxidant, antimicrobial, and anticancer activities, network pharmacology analysis, and In-silico molecular docking simulation
PLoS One Infectious Diseases
Tilføjet 5.11.2024
14
High utility of bronchoalveolar lavage fluid metagenomic next-generation sequencing approach for etiological diagnosis of pneumonia
BMC Infectious Diseases
Tilføjet 3.11.2024
15
Not all carbapenem-resistant Pseudomonas aeruginosa strains are alike: tailoring antibiotic therapy based on resistance mechanisms
Current Opinion in Infectious Diseases
Tilføjet 1.11.2024
16
blaGES-producing ST654 comprises a quarter of all carbapenem-resistant Pseudomonas aeruginosa in blood isolates from 15 hospitals
Antimicrobial Agents And Chemotherapy
Tilføjet 1.11.2024
17
Molecular characterisation of virulence genes in bacterial pathogens from daycare centres in Ile-Ife, Nigeria: implications for infection control
BMC Infectious Diseases
Tilføjet 26.10.2024
18
Molecular identification and antimicrobial resistance patterns of enterobacterales in community urinary tract infections among indigenous women in Ecuador: addressing microbiological misidentification
BMC Infectious Diseases
Tilføjet 26.10.2024
19
Critical resistance to carbapenem and aminoglycosides in Pseudomonas aeruginosa: spread of blaNDM/16S methylase armA harboring isolates with intrinsic resistance mechanisms in Kerman, Iran
BMC Infectious Diseases
Tilføjet 26.10.2024
20
Urinary tract infections and catheter-associated urinary tract infections caused by Pseudomonas aeruginosa
Microbiology and Molecular Biology Reviews
Tilføjet 22.10.2024
21
Mechanisms leading to in vivo ceftazidime/avibactam resistance development during treatment of GES-5-producing Pseudomonas aeruginosa infections
Antimicrobial Agents And Chemotherapy
Tilføjet 21.10.2024
22
Unraveling the Genomic Diversity of the Pseudomonas putida Group: Exploring Taxonomy, Core Pangenome, and Antibiotic Resistance Mechanisms
FEMS Microbiology Reviews
Tilføjet 15.10.2024
23
Impact of bacterial co-isolation on treatment initiation and long-term prognosis of patients with nontuberculous mycobacterial pulmonary disease: analysis of a prospective cohort study
BMC Infectious Diseases
Tilføjet 10.10.2024
24
Disinfectants efficacy in reducing pathogens related to health-care infection associated in universities hospitals of Gorgan, North of Iran
BMC Infectious Diseases
Tilføjet 8.10.2024
25
In vitro activity of cefepime-enmetazobactam on carbapenem resistant Gram negatives
Clinical Microbiology and Infection
Tilføjet 6.10.2024
26
[Articles] Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 months
Lancet Respiratory Medicine
Tilføjet 2.10.2024
27
Incidence and predictors of ventilator-associated pneumonia using a competing risk analysis: a single-center prospective cohort study in Egypt
BMC Infectious Diseases
Tilføjet 26.09.2024
28
Evaluation of biocontrol efficacy of rhizosphere Pseudomonas aeruginosa for management of Phytophthora capsici of pepper
PLoS One Infectious Diseases
Tilføjet 21.09.2024
29
Epidemiological, clinical and microbiological characteristics of patients with biliary tract diseases with positive bile culture in a tertiary hospital
BMC Infectious Diseases
Tilføjet 19.09.2024
30
Exploring antibiotic-induced persister formation and bacterial persistence genes in clinical isolates from Burkina Faso
BMC Infectious Diseases
Tilføjet 18.09.2024
31
Novel humanized anti-PcrV monoclonal antibody COT-143 protects mice from lethal Pseudomonas aeruginosa infection via inhibition of toxin translocation by the type III secretion system
Antimicrobial Agents And Chemotherapy
Tilføjet 14.09.2024
32
The OprF porin as a potential target for the restoration of carbapenem susceptibility in Pseudomonas aeruginosa expressing acquired carbapenemases
Antimicrobial Agents And Chemotherapy
Tilføjet 13.09.2024
33
Efficacy and safety of colistin plus beta-lactams for bone and joint infection caused by fluoroquinolone-resistant gram-negative bacilli: a prospective multicenter study
Infection
Tilføjet 12.09.2024
34
Clinical outcomes and emergence of resistance of Pseudomonas aeruginosa infections treated with ceftolozane-tazobactam versus ceftazidime-avibactam
Antimicrobial Agents And Chemotherapy
Tilføjet 5.09.2024
35
Duration of antibiotic therapy for multidrug resistant Pseudomonas aeruginosa pneumonia: is shorter truly better?
BMC Infectious Diseases
Tilføjet 5.09.2024
36
Ceftazidime-avibactam versus other antimicrobial agents for treatment of Multidrug-resistant Pseudomonas aeruginosa: a systematic review and meta-analysis
Infection
Tilføjet 2.09.2024
37
Estimating the value of new antibiotic treatment strategies in Zhejiang province, China: cost-effectiveness analysis based on a validated dynamic model
BMJ Open
Tilføjet 30.08.2024
38
Bacillus lipopeptides as key players in rhizosphere chemical ecology
Trends in Microbiology
Tilføjet 30.08.2024
39
Lower respiratory tract microbiota in patients with clinically suspected nontuberculous mycobacterial pulmonary disease according to the presence of gastroesophageal reflux
PLoS One Infectious Diseases
Tilføjet 29.08.2024
40
Burden of multidrug-resistant bacteria among HIV-positive individuals in Ethiopia: A systematic review and meta-analysis
PLoS One Infectious Diseases
Tilføjet 27.08.2024
41
Azotobacter vinelandii
Trends in Microbiology
Tilføjet 21.08.2024
42
Prevalence of carbapenem-resistant gram-negative bacteria among neonates suspected for sepsis in Africa: a systematic review and meta-analysis
BMC Infectious Diseases
Tilføjet 19.08.2024
43
Key summary of German national guideline for adult patients with nosocomial pneumonia- Update 2024 Funding number at the Federal Joint Committee (G-BA): 01VSF22007
Infection
Tilføjet 15.08.2024
44
A case of primary cutaneous Cryptococcus neoformans infection
BMC Infectious Diseases
Tilføjet 14.08.2024
45
Tracing the origin of NDM-1-producing and extensively drug-resistant Pseudomonas aeruginosa ST357 in the Netherlands
BMC Infectious Diseases
Tilføjet 14.08.2024
46
Improvement of a mouse infection model to capture Pseudomonas aeruginosa chronic physiology in cystic fibrosis
Proceedings of the National Academy of Sciences
Tilføjet 14.08.2024
47
Antimicrobial resistance profile of Pseudomonas aeruginosa clinical isolates from healthcare-associated infections in Ethiopia: A systematic review and meta-analysis
PLoS One Infectious Diseases
Tilføjet 14.08.2024
48
ARGONAUT-III and -V: susceptibility of carbapenem-resistant Klebsiella pneumoniae and multidrug-resistant Pseudomonas aeruginosa to the bicyclic boronate β-lactamase inhibitor taniborbactam combined with cefepime
Antimicrobial Agents And Chemotherapy
Tilføjet 13.08.2024
49
Outcomes of inadequate empiric therapy and timing of newer antibacterial therapy in hospitalized adults with culture-positive Enterobacterales and Pseudomonas aeruginosa: a multicenter analysis
BMC Infectious Diseases
Tilføjet 10.08.2024
50
Microbial contamination of spittoons and germicidal effect of irradiation with krypton chloride excimer lamps (Far UV-C 222 nm)
PLoS One Infectious Diseases
Tilføjet 8.08.2024